FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Harm Snippe

Research Profile

Living Beings

Chemicals & Drugs

Physiology

Antibody Formation

Procedures

Disorders

Togaviridae Infections

Co-author Network

Publications

TOP 3
Dodi Safari; Yulong Shan; Huberta A Th Dekker; Roberto Adamo; Fabrizio Chiodo; Johannis P Kamerling; Martina Lahmann; Marco Marradi; Stefan Oscarson; Soledad Penadés; Ger T Rijkers; Harm Snippe
Gold nanoparticles as carriers for a synthetic Streptococcus pneumoniae type 14 conjugate vaccine.
Dodi Safari; Huberta A T Dekker; Johannis P Kamerling; Ger T Rijkers; Arie van der Ende; Harm Snippe
The immune response to group B streptococcus type III capsular polysaccharide is directed to the -Glc-GlcNAc-Gal- backbone epitope.
Eileen Png; Greet J Boland; Rick T H Ong; Harm Snippe; Anbupalam Thalamuthu; Mark Seielstad
A genome-wide association study of hepatitis B vaccine response in an Indonesian population reveals multiple independent risk variants in the HLA region.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Harm Snippe (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Dodi Safari; Yulong Shan; Huberta A Th Dekker; Roberto Adamo; Fabrizio Chiodo; Johannis P Kamerling; Martina Lahmann; Marco Marradi; Stefan Oscarson; Soledad Penadés; Ger T Rijkers; Harm Snippe
Gold nanoparticles as carriers for a synthetic Streptococcus pneumoniae type 14 conjugate vaccine.
Nanomedicine (London, England) 2012;7(5):651-62.
2011: Dodi Safari; Huberta A T Dekker; Johannis P Kamerling; Ger T Rijkers; Arie van der Ende; Harm Snippe
The immune response to group B streptococcus type III capsular polysaccharide is directed to the -Glc-GlcNAc-Gal- backbone epitope.
Glycoconjugate journal 2011;28(8-9):557-62.
2011: Eileen Png; Greet J Boland; Rick T H Ong; Harm Snippe; Anbupalam Thalamuthu; Mark Seielstad
A genome-wide association study of hepatitis B vaccine response in an Indonesian population reveals multiple independent risk variants in the HLA region.
Human molecular genetics 2011;20(19):3893-8.
2011: Dodi Safari; Ben de Jong; Huberta A Th Dekker; Johannis P Kamerling; Ger T Rijkers; Harm Snippe
Antibody- and cell-mediated immune responses to a synthetic oligosaccharide conjugate vaccine after booster immunization.
Vaccine 2011;29(38):6498-504.
2011: Dodi Safari; Huberta A Th Dekker; Ger Rijkers; Harm Snippe
Codelivery of adjuvants at the primary immunization site is essential for evoking a robust immune response to neoglycoconjugates.
Vaccine 2011;29(4):849-54.
2008: Dodi Safari; Huberta A T Dekker; John A F Joosten; Dirk Michalik; Adriana Carvalho de Souza; Roberto Adamo; Martina Lahmann; Andreas Sundgren; Stefan Oscarson; Johannis P Kamerling; Harm Snippe
Identification of the smallest structure capable of evoking opsonophagocytic antibodies against Streptococcus pneumoniae type 14.
Infection and immunity 2008;76(10):4615-23.
2005: David Tarragó; Julio Casal; Jesús Ruiz Contreras; José Tomás Ramos; Pablo Rojo; Harm Snippe; Wouter Jansen
Assessment of antibody response elicited by a 7-valent pneumococcal conjugate vaccine in pediatric human immunodeficiency virus infection.
Clinical and diagnostic laboratory immunology 2005;12(1):165-70.
2004: Wouter Jansen; Harm Snippe
Short-chain oligosaccharide protein conjugates as experimental pneumococcal vaccines.
The Indian journal of medical research 2004;119 Suppl():7-12.
2003: Dirk J Lefeber; Barry Benaissa-Trouw; Johannes Vliegenthart; Johannis P Kamerling; Wouter Jansen; Kees Kraaijeveld; Harm Snippe
Th1-directing adjuvants increase the immunogenicity of oligosaccharide-protein conjugate vaccines related to Streptococcus pneumoniae type 3.
Infection and immunity 2003;71(12):6915-20.
2001: Wouter Jansen; AF Verheul; G H Veeneman; J H van Boom; Harm Snippe
Revised interpretation of the immunological results obtained with pneumococcal polysaccharide 17F derived synthetic di-, tri- and tetrasaccharide conjugates in mice and rabbits.
Vaccine 2001;20(1-2):19-21.
2001: D P Fonseca; Barry Benaissa-Trouw; M van Engelen; CA Kraaijeveld; Harm Snippe; AF Verheul
Induction of cell-mediated immunity against Mycobacterium tuberculosis using DNA vaccines encoding cytotoxic and helper T-cell epitopes of the 38-kilodalton protein.
Infection and immunity 2001;69(8):4839-45.
2001: Barry Benaissa-Trouw; Dirk J Lefeber; Johannis P Kamerling; Johannes Vliegenthart; Kees Kraaijeveld; Harm Snippe
Synthetic polysaccharide type 3-related di-, tri-, and tetrasaccharide-CRM(197) conjugates induce protection against Streptococcus pneumoniae type 3 in mice.
Infection and immunity 2001;69(7):4698-701.
2001: Wouter Jansen; M Väkeväinen-Anttila; Helena Käyhty; Moon H Nahm; N Bakker; Jan Verhoef; Harm Snippe; AF Verheul
Comparison of a classical phagocytosis assay and a flow cytometry assay for assessment of the phagocytic capacity of sera from adults vaccinated with a pneumococcal conjugate vaccine.
Clinical and diagnostic laboratory immunology 2001;8(2):245-50.
2001: Wouter Jansen; S Hogenboom; MJ Thijssen; Johannis P Kamerling; Johannes Vliegenthart; Jan Verhoef; Harm Snippe; AF Verheul
Synthetic 6B di-, tri-, and tetrasaccharide-protein conjugates contain pneumococcal type 6A and 6B common and 6B-specific epitopes that elicit protective antibodies in mice.
Infection and immunity 2001;69(2):787-93.
2001: IM Fernández; N A Bos; M Harmsen; AF Verheul; Harm Snippe; CA Kraaijeveld
Homology of ab1 and ab3 monoclonal antibodies that neutralize Semliki Forest virus.
Viral immunology 2001;14(2):119-24.
2000: D P da Fonseca; J Frerichs; M Singh; Harm Snippe; AF Verheul
Induction of antibody and T-cell responses by immunization with ISCOMS containing the 38-kilodalton protein of Mycobacterium tuberculosis.
Vaccine 2000;19(1):122-31.
2000: D P Fonseca; D Joosten; Harm Snippe; AF Verheul
Evaluation of T-cell responses to peptides and lipopeptides with MHC class I binding motifs derived from the amino acid sequence of the 19-kDa lipoprotein of Mycobacterium tuberculosis.
Molecular immunology 2000;37(8):413-22.
2000: Harm Snippe; Wouter Jansen; Johannis P Kamerling; Dirk J Lefeber
Towards a synthetic pneumococcal vaccine: synthetic oligosaccharides as tools for improving the specificity of enzyme-linked immunosorbent assays.
Clinical and diagnostic laboratory immunology 2000;7(2):325.
2000: JM Orendi; Hans S L M Nottet; NM de Vos; M R Visser; Harm Snippe; Charles A B Boucher; Jan Verhoef
Hydroxyurea interferes with antigen-dependent T-cell activation in vitro.
European journal of clinical investigation 2000;30(2):162-6.
1999: Wouter Jansen; Mijke A Breukels; Harm Snippe; Lieke A M Sanders; AF Verheul; Ger T Rijkers
Fcgamma receptor polymorphisms determine the magnitude of in vitro phagocytosis of Streptococcus pneumoniae mediated by pneumococcal conjugate sera.
The Journal of infectious diseases 1999;180(3):888-91.
1999: Jan Verhoef; Harm Snippe; Hans S L M Nottet
Christiaan Eijkman. First bacteriologist at Utrecht University, Nobel laureate for his work on vitamins.
Antonie van Leeuwenhoek 1999;75(3):165-9.
1998: IM Fernández; Hana Golding; Barry Benaissa-Trouw; NM de Vos; M Harmsen; Hans S L M Nottet; Basil Golding; Wouter C Puijk; Rob H Meloen; Harm Snippe; CA Kraaijeveld
Induction of HIV-1 IIIb neutralizing antibodies in BALB/c mice by a chimaeric peptide consisting of a T-helper cell epitope of Semliki Forest virus and a B-cell epitope of HIV.
Vaccine 1998;16(20):1936-40.
1998: JM Orendi; A C Bloem; Jan C C Borleffs; F J Wijnholds; NM de Vos; Hans S L M Nottet; M R Visser; Harm Snippe; Jan Verhoef; Charles A B Boucher
Activation and cell cycle antigens in CD4+ and CD8+ T cells correlate with plasma human immunodeficiency virus (HIV-1) RNA level in HIV-1 infection.
The Journal of infectious diseases 1998;178(5):1279-87.
1998: IM Fernández; M Harmsen; Barry Benaissa-Trouw; I Stuij; W Puyk; Rob H Meloen; Harm Snippe; CA Kraaijeveld
Epitope polarity and adjuvants influence the fine specificity of the humoral response against Semliki Forest virus specific peptide vaccines.
Vaccine 1998;16(16):1531-6.
1998: Wouter Jansen; J Gootjes; M Zelle; D V Madore; Jan Verhoef; Harm Snippe; AF Verheul
Use of highly encapsulated Streptococcus pneumoniae strains in a flow-cytometric assay for assessment of the phagocytic capacity of serotype-specific antibodies.
Clinical and diagnostic laboratory immunology 1998;5(5):703-10.
1998: D P da Fonseca; D Joosten; R van der Zee; D L Jue; M Singh; Martin Vordermeier; Harm Snippe; AF Verheul
Identification of new cytotoxic T-cell epitopes on the 38-kilodalton lipoglycoprotein of Mycobacterium tuberculosis by using lipopeptides.
Infection and immunity 1998;66(7):3190-7.
1998: C J De Haas; NM de Vos; M R Visser; Harm Snippe; Jan Verhoef
Monocytes modulate enhancement of HIV-1 replication by Mycobacterium tuberculosis.
Clinical and experimental immunology 1998;111(2):286-92.
1997: Wendy S Chaka; AF Verheul; VV Vaishnav; R Cherniak; Jelle Scharringa; Jan Verhoef; Harm Snippe; Andy I M Hoepelman
Induction of TNF-alpha in human peripheral blood mononuclear cells by the mannoprotein of Cryptococcus neoformans involves human mannose binding protein.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(6):2979-85.
1997: CA Benne; M Harmsen; W van der Graaff; AF Verheul; Harm Snippe; CA Kraaijeveld
Influenza virus neutralizing antibodies and IgG isotype profiles after immunization of mice with influenza A subunit vaccine using various adjuvants.
Vaccine 1997;15(9):1039-44.
1997: JM Orendi; AF Verheul; NM de Vos; M R Visser; Harm Snippe; R Cherniak; VV Vaishnav; Ger T Rijkers; Jan Verhoef
Mannoproteins of Cryptococcus neoformans induce proliferative response in human peripheral blood mononuclear cells (PBMC) and enhance HIV-1 replication.
Clinical and experimental immunology 1997;107(2):293-9.
1997: Wendy S Chaka; AF Verheul; VV Vaishnav; R Cherniak; Jelle Scharringa; Jan Verhoef; Harm Snippe; IM Hoepelman
Cryptococcus neoformans and cryptococcal glucuronoxylomannan, galactoxylomannan, and mannoprotein induce different levels of tumor necrosis factor alpha in human peripheral blood mononuclear cells.
Infection and immunity 1997;65(1):272-8.
1995: E AlonsoDeVelasco; AF Verheul; Jan Verhoef; Harm Snippe
Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines.
Microbiological reviews 1995;59(4):591-603.
1995: E Alonso De Velasco; B A Dekker; AF Verheul; R G Feldman; Jan Verhoef; Harm Snippe
Anti-polysaccharide immunoglobulin isotype levels and opsonic activity of antisera: relationships with protection against Streptococcus pneumoniae infection in mice.
The Journal of infectious diseases 1995;172(2):562-5.
1995: E A de Velasco; D Merkus; SM Anderton; AF Verheul; E F Lizzio; Ruurd van der Zee; Willem van Eden; T Hoffman; Jan Verhoef; Harm Snippe
Synthetic peptides representing T-cell epitopes act as carriers in pneumococcal polysaccharide conjugate vaccines.
Infection and immunity 1995;63(3):961-8.
1994: AF Verheul; A J Kuipers; AK Braat; H A Dekker; C C Peeters; Harm Snippe; Jan Poolman
Development, characterization, and biological properties of meningococcal immunotype L3,7,(8),9-specific monoclonal antibodies.
Clinical and diagnostic laboratory immunology 1994;1(6):729-36.
1994: E A DeVelasco; H A Dekker; P Antal; K P Jalink; Jos van Strijp; AF Verheul; Jan Verhoef; Harm Snippe
Adjuvant Quil A improves protection in mice and enhances opsonic capacity of antisera induced by pneumococcal polysaccharide conjugate vaccines.
Vaccine 1994;12(15):1419-22.
1994: JM Orendi; Hans S L M Nottet; Maarten R Visser; AF Verheul; Harm Snippe; Jan Verhoef
Enhancement of HIV-1 replication in peripheral blood mononuclear cells by Cryptococcus neoformans is monocyte-dependent but tumour necrosis factor-independent.
AIDS (London, England) 1994;8(4):423-9.
1994: E Alonso de Velasco; AF Verheul; A M van Steijn; H A Dekker; R G Feldman; I M Fernández; Johannis P Kamerling; Johannes Vliegenthart; Jan Verhoef; Harm Snippe
Epitope specificity of rabbit immunoglobulin G (IgG) elicited by pneumococcal type 23F synthetic oligosaccharide- and native polysaccharide-protein conjugate vaccines: comparison with human anti-polysaccharide 23F IgG.
Infection and immunity 1994;62(3):799-808.
1994: I M Fernández; W Ovaa; M Harmsen; Barry Benaissa-Trouw; N A Bos; CA Kraaijeveld; Harm Snippe
A shared idiotope among antibodies against Semliki Forest virus.
Viral immunology 1994;7(2):71-80.
1993: E Alonso de Velasco; AF Verheul; G H Veeneman; L J Gomes; J H van Boom; Jan Verhoef; Harm Snippe
Protein-conjugated synthetic di- and trisaccharides of pneumococcal type 17F exhibit a different immunogenicity and antigenicity than tetrasaccharide.
Vaccine 1993;11(14):1429-36.
1993: CA Kraaijeveld; T A Oosterlaken; F Vlaspolder; P W van Dijk; M Harmsen; I M Fernández; Barry Benaissa-Trouw; Harm Snippe
Detection of a shared idiotope on two encephalomyocarditis virus neutralizing monoclonal antibodies by neutralization inhibition enzyme immunoassay.
Journal of virological methods 1993;44(2-3):319-28.
1993: I M Fernández; A Snijders; Barry Benaissa-Trouw; M Harmsen; Harm Snippe; CA Kraaijeveld
Influence of epitope polarity and adjuvants on the immunogenicity and efficacy of a synthetic peptide vaccine against Semliki Forest virus.
Journal of virology 1993;67(10):5843-8.
1993: M Harmsen; T A Oosterlaken; C Tangerman; Harm Snippe; CA Kraaijeveld
Detection by a solid phase independent enzyme immunoassay of monoclonal anti-idiotypic antibodies against monoclonal antibodies neutralizing Semliki Forest virus and encephalomyocarditis virus.
Journal of virological methods 1993;43(2):137-46.
1993: AF Verheul; Harm Snippe; Jan Poolman
Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.
Microbiological reviews 1993;57(1):34-49.
1993: AF Verheul; J A Van Gaans; E J Wiertz; Harm Snippe; Jan Verhoef; Jan Poolman
Meningococcal lipopolysaccharide (LPS)-derived oligosaccharide-protein conjugates evoke outer membrane protein- but not LPS-specific bactericidal antibodies in mice: influence of adjuvants.
Infection and immunity 1993;61(1):187-96.
1992: A Snijders; Barry Benaissa-Trouw; H J Visser-Vernooy; I Fernandez; Harm Snippe; CA Kraaijeveld
A delayed-type hypersensitivity-inducing T-cell epitope of Semliki Forest virus mediates effective T-helper activity for antibody production.
Immunology 1992;77(3):322-9.
1992: CA Kraaijeveld; T A Oosterlaken; A Snijders; Barry Benaissa-Trouw; G L Ekstijn; Harm Snippe
A vaccine against Semliki Forest virus consisting of a monoclonal anti-idiotypic antibody cross-linked to a protein which contains virus-specific T-helper cell epitopes.
Antiviral research 1992;19(4):275-84.
1992: A Snijders; Barry Benaissa-Trouw; Harm Snippe; CA Kraaijeveld
Immunogenicity and vaccine efficacy of synthetic peptides containing Semliki Forest virus B and T cell epitopes.
The Journal of general virology 1992;73 ( Pt 9)():2267-72.
1992: T A Oosterlaken; M Harmsen; G L Ekstijn; CA Kraaijeveld; Harm Snippe
IgVH determined genetic restriction of a non-internal image monoclonal anti-idiotypic vaccine against Semliki Forest virus.
Immunology 1992;75(2):224-31.
1991: AF Verheul; Jan Poolman; Harm Snippe; Jan Verhoef
The influence of the adjuvant Quil A on the epitope specificity of meningococcal lipopolysaccharide anti-carbohydrate antibodies.
Molecular immunology 1991;28(11):1193-200.
1991: AF Verheul; Gerardus Josephus Boons; G A Van der Marel; J H Van Boom; H J Jennings; Harm Snippe; Jan Verhoef; Peter Hoogerhout; Jan Poolman
Minimal oligosaccharide structures required for induction of immune responses against meningococcal immunotype L1, L2, and L3,7,9 lipopolysaccharides determined by using synthetic oligosaccharide-protein conjugates.
Infection and immunity 1991;59(10):3566-73.
1991: J H van de Wijgert; AF Verheul; Harm Snippe; I J Check; R L Hunter
Immunogenicity of Streptococcus pneumoniae type 14 capsular polysaccharide: influence of carriers and adjuvants on isotype distribution.
Infection and immunity 1991;59(8):2750-7.
1991: AF Verheul; AK Braat; J M Leenhouts; Peter Hoogerhout; Jan Poolman; Harm Snippe; Jan Verhoef
Preparation, characterization, and immunogenicity of meningococcal immunotype L2 and L3,7,9 phosphoethanolamine group-containing oligosaccharide-protein conjugates.
Infection and immunity 1991;59(3):843-51.
1991: A Snijders; Barry Benaissa-Trouw; T A Oosterlaken; W C Puijk; W P Posthumus; R H Meloen; W A Boere; J D Oosting; CA Kraaijeveld; Harm Snippe
Identification of linear epitopes on Semliki Forest virus E2 membrane protein and their effectiveness as a synthetic peptide vaccine.
The Journal of general virology 1991;72 ( Pt 3)():557-65.
1991: T A Oosterlaken; A Brandenburg; Peter Schielen; R Fransen; CA Kraaijeveld; Harm Snippe
Efficient induction of Semliki Forest virus and mumps virus neutralizing anti-anti-idiotypic antibodies using Quil A as adjuvant.
Journal of immunological methods 1991;136(2):169-75.
1991: T A Oosterlaken; M Harmsen; S S Jhagjhoor-Singh; G L Ekstijn; CA Kraaijeveld; Harm Snippe
A protective monoclonal anti-idiotypic vaccine to lethal Semliki Forest virus infection in BALB/c mice.
Journal of virology 1991;65(1):98-102.
1990: J E van Dam; A Fleer; Harm Snippe
Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.
Antonie van Leeuwenhoek 1990;58(1):1-47.
1990: T A Oosterlaken; M Harmsen; CA Kraaijeveld; Harm Snippe
Blocking by anti-idiotypic antibodies of monoclonal antibody-mediated protection against lethal Semliki Forest virus in mice.
Scandinavian journal of immunology 1990;31(2):159-65.
1990: AF Verheul; A A Versteeg; N A Westerdaal; Govert van Dam; M Jansze; Harm Snippe
Measurement of the humoral immune response against Streptococcus pneumoniae type 14-derived antigens by an ELISA and ELISPOT assay based on biotin-avidin technology.
Journal of immunological methods 1990;126(1):79-87.
1990: F Vlaspolder; T A Oosterlaken; M Harmsen; P W van Dijk; H Kievit; CA Kraaijeveld; Harm Snippe
Blocking by anti-idiotypic antibodies of monoclonal antibody mediated protection in mice against encephalomyocarditis virus induced diabetes and lethal disease.
Archives of virology 1990;110(3-4):277-85.
1989: Govert van Dam; AF Verheul; G J Zigterman; M J De Reuver; Harm Snippe
Nonionic block polymer surfactants enhance the avidity of antibodies in polyclonal antisera against Streptococcus pneumoniae type 3 in normal and Xid mice.
Journal of immunology (Baltimore, Md. : 1950) 1989;143(9):3049-53.
1989: A Snijders; Barry Benaissa-Trouw; J D Oosting; Harm Snippe; CA Kraaijeveld
Identification of a DTH-inducing T-cell epitope on the E2 membrane protein of Semliki Forest virus.
Cellular immunology 1989;123(1):23-35.
1989: G J Zigterman; K Schotanus; E B Ernste; Govert van Dam; M Jansze; Harm Snippe; J M Willers
Nonionic block polymer surfactants modulate the humoral immune response against Streptococcus pneumoniae-derived hexasaccharide-protein conjugates.
Infection and immunity 1989;57(9):2712-8.
1989: T A Oosterlaken; F Vlaspolder; R Fransen; T Harmsen; CA Kraaijeveld; Harm Snippe
Competition binding assay in cell culture for identification of epitopes on enveloped and naked viruses.
Zentralblatt für Bakteriologie : international journal of medical microbiology 1989;271(2):237-43.
1989: AF Verheul; A A Versteeg; M J De Reuver; M Jansze; Harm Snippe
Modulation of the immune response to pneumococcal type 14 capsular polysaccharide-protein conjugates by the adjuvant Quil A depends on the properties of the conjugates.
Infection and immunity 1989;57(4):1078-83.
1989: F Vlaspolder; E Donkers; T Harmsen; CA Kraaijeveld; Harm Snippe
Rapid bioassay of human interferon by direct enzyme immunoassay of encephalomyocarditis virus in HEp-2 cell monolayers after a single cycle of infection.
Journal of virological methods 1989;24(1-2):153-8.
1989: Govert van Dam; AF Verheul; G J Zigterman; M J de Reuver; Harm Snippe
Estimation of the avidity of antibodies in polyclonal antisera against Streptococcus pneumoniae type 3 by inhibition ELISA.
Molecular immunology 1989;26(3):269-74.
1989: Jos van Strijp; Kok P M van Kessel; M E van der Tol; Ad C Fluit; Harm Snippe; Jan Verhoef
Phagocytosis of herpes simplex virus by human granulocytes and monocytes.
Archives of virology 1989;104(3-4):287-98.
1988: T A Oosterlaken; M Harmsen; C Tangerman; Peter Schielen; CA Kraaijeveld; Harm Snippe
A neutralization-inhibition enzyme immunoassay for anti-idiotypic antibodies that block monoclonal antibodies neutralizing Semliki Forest virus.
Journal of immunological methods 1988;115(2):255-61.
1988: F Vlaspolder; T Harmsen; D van Veenendaal; CA Kraaijeveld; Harm Snippe
Application of immunoassay of encephalomyocarditis virus in cell culture with enzyme-labeled virus-specific monoclonal antibodies for rapid detection of virus, neutralizing antibodies, and interferon.
Journal of clinical microbiology 1988;26(12):2593-7.
1988: Frank van Tiel; CA Kraaijeveld; J Baller; T Harmsen; T A Oosterlaken; Harm Snippe
Enzyme immunoassay of mumps virus in cell culture with peroxidase-labelled virus specific monoclonal antibodies and its application for determination of antibodies.
Journal of virological methods 1988;22(1):99-108.
1988: G J Zigterman; M Jansze; Harm Snippe; J M Willers
Stimulation of liposome-induced humoral immune responses by non-ionic block polymer surfactants in Xid mice.
Immunology 1988;65(1):37-42.
1988: G J Zigterman; Harm Snippe; M Jansze; E B Ernste; M J De Reuver; J M Willers
Nonionic block polymer surfactants enhance immunogenicity of pneumococcal hexasaccharide-protein vaccines.
Infection and immunity 1988;56(5):1391-3.
1988: F Vlaspolder; CA Kraaijeveld; T Oosterlaken; R van Buuren; Barry Benaissa-Trouw; Harm Snippe
Discrimination of determinant specificity of two encephalomyocarditis virus neutralizing monoclonal antibodies by competition, mixed neutralization and anti-idiotypic antibodies.
Journal of virological methods 1988;20(1):13-20.
1988: G J Zigterman; AF Verheul; E B Ernste; R F Rombouts; M J De Reuver; M Jansze; Harm Snippe; J M Willers
Measurement of the humoral immune response against Streptococcus pneumoniae type 3 capsular polysaccharide and oligosaccharide containing antigens by ELISA and ELISPOT techniques.
Journal of immunological methods 1988;106(1):101-7.
1988: F Vlaspolder; CA Kraaijeveld; R van Buuren; M Harmsen; Barry Benaissa-Trouw; Harm Snippe
Prophylaxis and therapy of virulent encephalomyocarditis virus infection in mice by monoclonal antibodies. Brief report.
Archives of virology 1988;98(1-2):123-30.
1988: L A Hilgers; M J de Reuver; A R Vaandrager; T Ong; Harm Snippe; J M Willers
Serum amyloid P component induction by immunomodulators.
Natural immunity and cell growth regulation 1988;7(5-6):328-33.
1988: T A Oosterlaken; CA Kraaijeveld; A Snijders; M Harmsen; Barry Benaissa-Trouw; Harm Snippe
Discrimination of the determinant specificity of two competitive Semliki Forest virus neutralizing monoclonal antibodies by anti-idiotypic antibodies.
Archives of virology 1988;100(1-2):115-20.
1987: G J Zigterman; Harm Snippe; M Jansze; J M Willers
Adjuvant effects of nonionic block polymer surfactants on liposome-induced humoral immune response.
Journal of immunology (Baltimore, Md. : 1950) 1987;138(1):220-5.
1987: L A Hilgers; Harm Snippe; M Jansze; J M Willers
Synthetic sulpholipopolysaccharides: novel adjuvants for humoral immune responses.
Immunology 1987;60(1):141-6.
1986: Frank van Tiel; T Harmsen; M Wagenaar; W A Boere; CA Kraaijeveld; Harm Snippe
Rapid determination of neutralizing antibodies to Semliki Forest virus in serum by enzyme immunoassay in cell culture with virus-specific monoclonal antibodies.
Journal of clinical microbiology 1986;24(4):665-8.
1986: Frank van Tiel; M Harmsen; CA Kraaijeveld; Harm Snippe
Inhibition of Semliki Forest virus multiplication by ribavirin: a potential method for the monitoring of antiviral agents in serum.
Journal of virological methods 1986;14(2):119-25.
1986: W A Boere; Barry Benaissa-Trouw; T Harmsen; T Erich; CA Kraaijeveld; Harm Snippe
The role of complement in monoclonal antibody-mediated protection against virulent Semliki Forest virus.
Immunology 1986;58(4):553-9.
1986: L A Hilgers; Harm Snippe; K E van Vliet; M Jansze; J M Willers
Suppression of the cellular adjuvanticity of lipophilic amines by a polyanion.
International archives of allergy and applied immunology 1986;80(3):320-5.
1986: G J Zigterman; M Jansze; Harm Snippe; J M Willers
Immunomodulating properties of substances to be used in combination with liposomes.
International archives of allergy and applied immunology 1986;81(3):245-52.
1986: CA Kraaijeveld; Barry Benaissa-Trouw; M Harmsen; Harm Snippe
Adoptive transfer of immunity against virulent Semliki Forest virus with immune spleen cells from mice infected with avirulent Semliki Forest virus.
Archives of virology 1986;91(1-2):83-92.
1986: CA Kraaijeveld; W Kamphuis; Barry Benaissa-Trouw; H van Haarlem; M Harmsen; Harm Snippe
Potentiation of the cellular immune response by adjuvants: a limited role for adjuvant induced interferon.
International archives of allergy and applied immunology 1986;81(2):148-55.
1986: W A Boere; M Harmsen; CA Kraaijeveld; Harm Snippe
Antigenic differences between virulent and avirulent strains of Semliki Forest viruses detected with monoclonal antibodies. Brief report.
Archives of virology 1986;88(1-2):105-12.
1986: L A Hilgers; Harm Snippe; M Jansze; J M Willers
Synergistic effects of synthetic adjuvants on the humoral immune response.
International archives of allergy and applied immunology 1986;79(4):392-6.
1986: L A Hilgers; Harm Snippe; M Jansze; J M Willers
Route-dependent immunomodulation: local stimulation by a surfactant and systemic stimulation by a polyanion.
International archives of allergy and applied immunology 1986;79(4):388-91.
1986: CA Kraaijeveld; W Kamphuis; Barry Benaissa-Trouw; M Harmsen; Harm Snippe
Modulation of adjuvant-enhanced delayed-type hypersensitivity by the interferon inducers poly I:C and Newcastle disease virus.
International archives of allergy and applied immunology 1986;79(1):86-9.
1985: Frank van Tiel; W A Boere; T Harmsen; Barry Benaissa-Trouw; CA Kraaijeveld; Harm Snippe
Enzyme immunoassay of interferon with peroxidase-labelled virus-specific monoclonal antibodies.
The Journal of general virology 1985;66 ( Pt 6)():1353-6.
1985: Frank van Tiel; W A Boere; T Harmsen; CA Kraaijeveld; Harm Snippe
Determination of inhibitory concentrations of antiviral agents in cell culture by use of an enzyme immunoassay with virus-specific, peroxidase-labeled monoclonal antibodies.
Antimicrobial agents and chemotherapy 1985;27(5):802-5.
1985: W A Boere; Barry Benaissa-Trouw; T Harmsen; T Erich; CA Kraaijeveld; Harm Snippe
Mechanisms of monoclonal antibody-mediated protection against virulent Semliki Forest virus.
Journal of virology 1985;54(2):546-51.
1985: L A Hilgers; Harm Snippe; M Jansze; J M Willers
Combinations of two synthetic adjuvants: synergistic effects of a surfactant and a polyanion on the humoral immune response.
Cellular immunology 1985;92(2):203-9.
1985: L A Hilgers; Harm Snippe; M Jansze; J M Willers
Effect of in vivo administration of different adjuvants on the in vitro candidacidal activity of mouse peritoneal cells.
Cellular immunology 1985;90(1):14-23.
1985: Frank van Tiel; T Harmsen; W A Boere; CA Kraaijeveld; Harm Snippe
Rapid detection of Semliki Forest virus replication in cell culture with peroxidase-labeled monoclonal antibodies: determination of inhibitory concentrations of monoclonal antibodies and ribavirin.
Antiviral research 1985;Suppl 1():101-6.
1985: W A Boere; CA Kraaijeveld; Harm Snippe
Aspects of monoclonal antibody-mediated protection of mice against infection with virulent Semliki Forest virus.
Antiviral research 1985;Suppl 1():149-53.
1984: W A Boere; T Harmsen; Jan Vinjé; Barry Benaissa-Trouw; CA Kraaijeveld; Harm Snippe
Identification of distinct antigenic determinants on Semliki Forest virus by using monoclonal antibodies with different antiviral activities.
Journal of virology 1984;52(2):575-82.
1984: Frank van Tiel; W A Boere; Jan Vinjé; T Harmsen; Barry Benaissa-Trouw; CA Kraaijeveld; Harm Snippe
Detection of Semliki Forest virus in cell culture by use of an enzyme immunoassay with peroxidase-labeled monoclonal antibodies specific for glycoproteins E1 and E2.
Journal of clinical microbiology 1984;20(3):387-90.
1984: L A Hilgers; Harm Snippe; M Jansze; J M Willers
Immunomodulating properties of two synthetic adjuvants: dependence upon type of antigen, dose, and time of administration.
Cellular immunology 1984;86(2):393-401.
1984: Harm Snippe; A J Van Houte; J K Inman; E F Lizzio; B Merchant
Hapten-specific B cell blockade of the immune response to a thymus-independent-1 antigen produced by concomitant administration of a thymus-independent-2 antigen.
Immunology 1984;52(1):87-96.
1983: Harm Snippe; J E van Dam; A J van Houte; J M Willers; J P Kamerling; J F Vliegenthart
Preparation of a semisynthetic vaccine to Streptococcus pneumoniae type 3.
Infection and immunity 1983;42(2):842-4.
1983: CA Kraaijeveld; G la Rivière; Barry Benaissa-Trouw; J Jansen; T Harmsen; Harm Snippe
Effect of the adjuvant dimethyl dioctadecyl ammonium bromide on the humoral and cellular immune responses to encephalomyocarditis virus.
Antiviral research 1983;3(3):137-49.
1983: W A Boere; Barry Benaissa-Trouw; M Harmsen; CA Kraaijeveld; Harm Snippe
Neutralizing and non-neutralizing monoclonal antibodies to the E2 glycoprotein of Semliki Forest virus can protect mice from lethal encephalitis.
The Journal of general virology 1983;64 (Pt 6)():1405-8.
1983: Harm Snippe; A J van Houte; J E van Dam; M J De Reuver; M Jansze; J M Willers
Immunogenic properties in mice of hexasaccharide from the capsular polysaccharide of Streptococcus pneumoniae type 3.
Infection and immunity 1983;40(3):856-61.
1982: CA Kraaijeveld; Harm Snippe; T Harmsen; Barry Benaissa-Trouw
Enhancement of delayed-type hypersensitivity and induction of interferon by the lipophilic agents DDA and CP-20,961.
Cellular immunology 1982;74(2):277-83.
1982: Harm Snippe; A J Van Houte; A Janssen; E F Lizzio; J M Willers; B Merchant
Characterization of immunogenic properties of haptenated liposomal model membranes in mice. VII. Synergistic responses to haptenated liposomes and haptenated thymus-dependent antigens in CBA/N mice.
Immunology 1982;45(4):613-20.
1982: Harm Snippe; A J van Houte; E F Lizzio; J M Willers; B Merchant
Characterization of immunogenic properties of haptenated liposomal model membranes in mice. VI. Response in B-cell-defective CBA/N mice.
Immunology 1982;45(3):545-51.
1982: Harm Snippe; M J De Reuver; E W Kamperdijk; M van den Berg; J M Willers
Adjuvanticity of dimethyl dioctadecyl ammonium bromide in guinea pigs. I. Skin test reactions.
International archives of allergy and applied immunology 1982;68(3):201-8.
1982: Harm Snippe; B Merchant; E F Lizzio; J K Inman
Functional antigen binding by the defective B cells of CBA/N mice.
Advances in experimental medicine and biology 1982;149():91-6.
1982: Harm Snippe; M J de Reuver; J W Beunder; J B van der Meer; D F van Wichen; J M Willers
Delayed-type hypersensitivity in rabbits. Comparison of the adjuvants dimethyl dioctadecyl ammonium bromide and Freund's complete adjuvant.
International archives of allergy and applied immunology 1982;67(2):139-44.
1981: A J van Houte; Harm Snippe; M G Schmitz; J M Willers
Characterization of immunogenic properties of haptenated liposomal model membranes in mice. V. Effect of membrane composition on humoral and cellular immunogenicity.
Immunology 1981;44(3):561-8.
1981: A J van Houte; Harm Snippe; J M Willers
Characterization of immunogenic properties of haptenated liposomal model membranes in mice. IV. induction of IgM memory.
Immunology 1981;43(4):627-34.
1981: A J van Houte; Harm Snippe; G T Peulen; J M Willers
Characterization of immunogenic properties of haptenated liposomal model membranes in mice.
Immunology 1981;42(2):233-9.
1981: Harm Snippe; M J De Reuver; F Strickland; J M Willers; R L Hunter
Adjuvant effect of nonionic block polymer surfactants in humoral and cellular immunity.
International archives of allergy and applied immunology 1981;65(4):390-8.
1981: A J van Houte; Harm Snippe; G T Peulen; J M Willers
Characterization of immunogenic properties of haptenated liposomal model membranes in mice. II. Induction of delayed-type hypersensitivity.
Immunology 1981;42(1):165-73.
1980: Harm Snippe; B Merchant; E Lizzio; J K Inman
Functional antigen binding by the defective B cells of CBA/N x C3H/HeN F1 male mice.
Journal of immunogenetics 1980;7(5):409-20.
1980: Harm Snippe; L Johannesen; E Lizzio; B Merchant
Variable expression of delayed hypersensitivity in different mouse strains using dimethyl dioctadecyl ammonium bromide as an adjuvant.
Immunology 1980;39(3):399-405.
1980: Harm Snippe; J M Willers; J K Inman; B Merchant
The specificity of antibody formation in mice following immunization with hapten-carrier complexes mixed with the surfactant, dimethyl dioctadecyl ammonium bromide.
Immunology 1980;39(3):361-6.
1980: Harm Snippe; B Merchant; E F Lizzio; J K Inman
Hapten-specific blockade of CBA/N x C3H/HeN F1 B cell responses in a cell transfer system.
International archives of allergy and applied immunology 1980;63(4):396-407.
1980: Harm Snippe; B Merchant; E F Lizzio; J K Inman
Localization of 125I-labeled DNP-ficoll on lymphoid cells from the normal and defective hybrid progeny of CBA/N mice.
International archives of allergy and applied immunology 1980;62(2):168-78.